Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

American Journal of Human Genetics

Volumn 70, Issue 3, 2002, Pages 708-717

  Schmidt, Silke ^a   Barcellos, Lisa F ^b   DeSombre, Karen ^a   Rimmler, Jacqueline B ^a   Lincoln, Robin R ^b   Bucher, Patricia ^b   Saunders, Ann M ^a   Lai, Eric ^c   Martin, Eden R ^a   Vance, Jeffery M ^a   Oksenberg, Jorge R ^b   Hauser, Stephen L ^b   Pericak Vance, Margaret A ^a   Haines, Jonathan L ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLAXOSMITHKLINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ARTICLE; CHROMOSOME 19Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FAMILY STUDY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 18244367936     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/339269     Document Type: Article

References (61)

1. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene
2. Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis
3. Genetic basis for clinical expression in multiple sclerosis
4. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis: Evidence of a new susceptibility locus in Caucasian and Chinese patients
5. Involvement of apolipoprotein E in multiple sclerosis: Absence of remyelination associated with possession of the APOE ε2 allele
6. APOE genotype is a major predictor of long-term progression of disability in MS
7. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen
8. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission
9. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
10. An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population
11. Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families
12. ApoE polymorphism in multiple sclerosis
13. A full genome search in multiple sclerosis
14. A genetic basis for familial aggregation in multiple sclerosis
15. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations
16. Association of the APOE ε4 allele with disease activity in multiple sclerosis
17. Apolipoprotein E epsilon4 is associated with rapid progression of multiple sclerosis
18. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis
19. APOE ε2-4 and -491 polymorphisms are not associated with MS
20. Apolipoprotein E and multiple sclerosis: A biochemical and genetic investigation
21. Diagnostic criteria for multiple sclerosis research involving multiply affected families
22. A genomic screen for multiple sclerosis loci in a San Marino population supports the presence of a locus on 19q
23. Genetic dissection of the multiple sclerosis phenotype
24. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
25. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity
26. Multiple Sclerosis and other demyelinating diseases
27. PEDIGENE: A comprehensive data management system to facilitate efficient and rapid disease gene mapping
28. Apolipoprotein E and multiple sclerosis: Impact of the ε-4 allele on susceptibility, clinical type and progression rate
29. Expression of apolipoprotein E during nerve degeneration and regeneration
30. Genomewide scan of multiple sclerosis in Finnish multiplex families
31. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
32. A 4-Mb high-density single nucleotide polymorphism-based map around human APOE
33. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
34. Apolipoprotein E and the CNS response to injury
35. The robust inference for the Cox proportional hazards model
36. Apolipoprotein E-e4 allele, the major risk factor for Alzheimer's disease, is also involved in the severity of multiple sclerosis
37. Correcting for a potential bias in the pedigree disequilibrium test
38. SNPing away at complex disease: Analysis of SNPs around APOE in Alzheimer disease
39. The pedigree disequilibrium test
40. Association of single-nucleotide polymorphisms of the τ gene with late-onset Parkinson disease
41. Differential effects of apolipoprotein E3 and E4 on neural growth in vitro
42. PedCheck: A program for identification of genotype incompatibilities in linkage analysis
43. APOE and risk of cognitive impairment in multiple sclerosis
44. Linkage and association analysis of chromosome 19q13 in multiple sclerosis
45. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster
46. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination
47. Development of a data coordinating center (DCC): Data quality control for complex disease studies
48. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: A critical overview
49. A population based study of multiple sclerosis in twins: Update
50. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
51. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
52. Descent graphs in pedigree analysis: Applications to haplotyping, location scores and marker-sharing statistics
53. The collection of biological samples for DNA analysis
54. Polymorphisms of apolipoprotein E: Outcome and susceptibility in multiple sclerosis
55. No association between the APOE ε4 allele and outcome and susceptibility in primary progressive multiple sclerosis
56. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
57. GEECAT and GEEGOR: Computer programs for the analysis of correlated categorical response data
58. Meta-analysis of genome searches
59. Exact tests for association between alleles at arbitrary numbers of loci
60. Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis